Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin Skin Flush Response in Schizophrenia and Bipolar Disorder
NCT02458924Phase 3Completed
- Start
- Jan 2014
- Primary completion
- Sep 2014
01
Overview
Phase 3, open-label trial (4 arms). Primary endpoint: Skin flush response at 20 minutes. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02458924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458924.